IDO1 and cancer: Moreover, IDO1 is a promising anticancer target for different cancer treatments including lung cancer whose function can be regulated by small candidate molecules and the process provides immune blockade opportunities outside the immune checkpoint inhibition and adoptive immune cell transfer (Du et al., 2019).